Produktbild
Elaine A Moore

Promise of Low Dose Naltrexone Therapy

Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders

Buch

Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects… Mehr

CHF 40.90

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

Produktdetails


Weitere Autoren: Wilkinson, Samantha
  • ISBN: 978-0-7864-3715-3
  • EAN: 9780786437153
  • Produktnummer: 3807638
  • Verlag: McFarland and Company, Inc.
  • Sprache: Englisch
  • Erscheinungsjahr: 2008
  • Seitenangabe: 224 S.
  • Masse: H22.9 cm x B15.2 cm x D1.2 cm 332 g
  • Abbildungen: Paperback
  • Gewicht: 332

Über den Autor


Elaine A. Moore has worked in hospital laboratories for more than 30 years, primarily in immunohematology and toxicology. She is a freelance medical writer and laboratory consultant.

23 weitere Werke von Elaine A Moore:


Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.